4.7 Article

Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients

S. Georgin-Lavialle et al.

Summary: VEXAS syndrome is a newly described autoinflammatory syndrome associated with somatic mutations of UBA1. It presents a wide range of clinical features, with different prognostic profiles identified, and the UBA1 p.Met41Leu mutation is associated with a better prognosis.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Hematology

Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry

Thibault Comont et al.

Summary: Azacitidine may be effective in MDS associated with inflammatory/autoimmune diseases. A study on 116 VEXAS patients in France found that azacitidine treatment achieved clinical response in 46% of patients, suggesting its potential effectiveness in selected VEXAS patients with MDS.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Allergy

Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS

Caspar van der Made et al.

Summary: A novel autoinflammatory syndrome called VEXAS has been discovered in male patients with somatic mutations in the UBA1 gene. This study retrospectively diagnosed VEXAS in previously unclassified autoinflammatory patients and described the clinical experiences with this complex disease. Through reanalysis of whole-exome sequencing data, 12 male patients with UBA1 mutations were identified. These patients experienced adult-onset autoinflammation with systemic symptoms, elevated inflammatory parameters, and multiorgan involvement, particularly affecting the skin and bone marrow. New features of VEXAS included interstitial nephritis, cardiac involvement, stroke, and intestinal perforation related to tocilizumab treatment. Despite various treatments, most patients were treatment-refractory, leading to a high mortality rate of 50%.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Letter Otorhinolaryngology

Ear, Nose, Throat, and Bronchial Involvements in VEXAS Syndrome Specifying the Spectrum of Clinical Features

Stacy Beaumesnil et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Letter Oncology

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome

Valentin Lacombe et al.

Summary: VEXAS syndrome is an inflammatory disorder with hematological and systemic features, and various skin involvements, including neutrophilic dermatitis, leukocytoclastic vasculitis, and septal panniculitis. A study found UBA1 gene mutation in skin biopsies related to neutrophilic dermatitis, which could distinguish clonal from paraclonal cutaneous involvements and improve therapeutic outcomes.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)

Review Medicine, General & Internal

Cryptogenic Organizing Pneumonia

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Study of Thoracic CT in COVID-19: The STOIC Project

Marie-Pierre Revel et al.

Summary: This study conducted a multicenter retrospective cohort study in 20 French university hospitals to evaluate the diagnostic and prognostic value of CT in COVID-19 pneumonia. The sensitivity and specificity of CT were 80.2% and 79.7%, respectively, with the extent of pneumonia at CT being the best predictor of severe outcome at 1 month.

RADIOLOGY (2021)

Article Rheumatology

Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

Marcela A. Ferrada et al.

Summary: Somatic mutations in UBA1 have been identified in a subset of patients with relapsing polychondritis (RP), leading to a newly defined syndrome called VEXAS-RP. Patients with VEXAS-RP have distinct clinical and immunologic features, including a male predominance, onset in midlife or later, specific symptoms, and higher mortality compared to typical RP patients. Early identification and intervention are important in managing VEXAS-RP due to its associated higher mortality rate.

ARTHRITIS & RHEUMATOLOGY (2021)

Letter Oncology

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder

Huijun Huang et al.

Summary: VEXAS syndrome is a newly-described adult-onset inflammatory syndrome characterized by vacuoles in myeloid and erythroid precursor cells and somatic mutations affecting methionine-41 (p.Met41) in UBA1. Patients with characteristic vacuoles in myeloid and erythroid precursor cells should be screened for UBA1 mutation to identify potential cases of VEXAS syndrome.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Letter Hematology

Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold

Valentin Lacombe et al.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Article Dermatology

UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome

Eve Zakine et al.

Summary: VEXAS syndrome is a severe adult-onset autoinflammatory disease associated with somatic variations in the UBA1 gene. This study describes the clinical and pathological features of skin lesions in VEXAS syndrome, which are characterized by neutrophilic dermatosis. The findings suggest that therapies targeting the pathological myeloid clone may be effective in managing the disease.

JAMA DERMATOLOGY (2021)

Letter Medicine, General & Internal

Mutant UBA1 and Severe Adult-Onset Autoinflammatory Disease

Jean-Benoit Arlet et al.

Summary: The authors report the occurrence of the VEXAS syndrome in two female patients, which was previously described exclusively in male patients. An 87-year-old woman presented with relapsing polychondritis, prolonged fever, and myelodysplastic syndrome.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

David B. Beck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Respiratory System

Management of suspected monogenic lung fibrosis in a specialised centre

Raphael Borie et al.

EUROPEAN RESPIRATORY REVIEW (2017)

Article Respiratory System

Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis

Raphael Borie et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis in United States Automated Claims Incidence, Prevalence, and Algorithm Validation

Daina B. Esposito et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Cell Biology

Uba1 functions in Atg7-and Atg3-independent autophagy

Tsun-Kai Chang et al.

NATURE CELL BIOLOGY (2013)

Review Radiology, Nuclear Medicine & Medical Imaging

Fleischner Society: Glossary of terms tor thoracic imaging

David M. Hansell et al.

RADIOLOGY (2008)

Review Respiratory System

Cryptogenic organising pneumonia

J. -F. Cordier

EUROPEAN RESPIRATORY JOURNAL (2006)